PSTV
Plus Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$34.49M
P/E Ratio
0.23
EPS
$21.56
Beta
1.37
52W High
$23.50
52W Low
$2.90
50-Day MA
$5.74
200-Day MA
$10.05
Dividend Yield
—
Profit Margin
-230.20%
Forward P/E
0.97
PEG Ratio
2.45
About Plus Therapeutics Inc
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing, and commercialization of treatments for patients with cancer and other diseases. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | $5.18M |
| Gross Profit (TTM) | $-4.31M |
| EBITDA | $-18.49M |
| Operating Margin | -693.00% |
| Return on Equity | -522.00% |
| Return on Assets | -73.80% |
| Revenue/Share (TTM) | $1.12 |
| Book Value | $1.74 |
| Price-to-Book | 2.88 |
| Price-to-Sales (TTM) | 6.66 |
| EV/Revenue | 18.19 |
| EV/EBITDA | 29.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -2.90% |
| Shares Outstanding | $6.88M |
| Float | $6.48M |
| % Insiders | 1.49% |
| % Institutions | 10.38% |
Historical Volatility
HV 10-Day
62.85%
HV 20-Day
91.18%
HV 30-Day
76.75%
HV 60-Day
123.99%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($36.00 target)
1
Strong Buy3
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026